Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

196 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.
Walsh M, Merkel PA, Peh CA, Szpirt WM, Puéchal X, Fujimoto S, Hawley CM, Khalidi N, Floßmann O, Wald R, Girard LP, Levin A, Gregorini G, Harper L, Clark WF, Pagnoux C, Specks U, Smyth L, Tesar V, Ito-Ihara T, de Zoysa JR, Szczeklik W, Flores-Suárez LF, Carette S, Guillevin L, Pusey CD, Casian AL, Brezina B, Mazzetti A, McAlear CA, Broadhurst E, Reidlinger D, Mehta S, Ives N, Jayne DRW; PEXIVAS Investigators. Walsh M, et al. Among authors: clark wf. N Engl J Med. 2020 Feb 13;382(7):622-631. doi: 10.1056/NEJMoa1803537. N Engl J Med. 2020. PMID: 32053298 Free PMC article. Clinical Trial.
Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial.
Walsh M, Merkel PA, Peh CA, Szpirt W, Guillevin L, Pusey CD, De Zoysa J, Ives N, Clark WF, Quillen K, Winters JL, Wheatley K, Jayne D; PEXIVAS Investigators. Walsh M, et al. Among authors: clark wf. Trials. 2013 Mar 14;14:73. doi: 10.1186/1745-6215-14-73. Trials. 2013. PMID: 23497590 Free PMC article. Clinical Trial.
Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCT.
Jayne D, Walsh M, Merkel PA, Peh CA, Szpirt W, Puéchal X, Fujimoto S, Hawley C, Khalidi N, Jones R, Flossmann O, Wald R, Girard L, Levin A, Gregorini G, Harper L, Clark W, Pagnoux C, Specks U, Smyth L, Ito-Ihara T, de Zoysa J, Brezina B, Mazzetti A, McAlear CA, Reidlinger D, Mehta S, Ives N, Brettell EA, Jarrett H, Wheatley K, Broadhurst E, Casian A, Pusey CD. Jayne D, et al. Health Technol Assess. 2022 Sep;26(38):1-60. doi: 10.3310/PNXB5040. Health Technol Assess. 2022. PMID: 36155131 Free article. Clinical Trial.
Plasmapheresis for the treatment of kidney diseases.
Clark WF, Huang SS, Walsh MW, Farah M, Hildebrand AM, Sontrop JM. Clark WF, et al. Kidney Int. 2016 Nov;90(5):974-984. doi: 10.1016/j.kint.2016.06.009. Epub 2016 Aug 3. Kidney Int. 2016. PMID: 27498206 Free article. Review.
Plasma exchange for kidney disease: what is the best evidence?
Hildebrand AM, Huang SH, Clark WF. Hildebrand AM, et al. Among authors: clark wf. Adv Chronic Kidney Dis. 2014 Mar;21(2):217-27. doi: 10.1053/j.ackd.2014.01.008. Adv Chronic Kidney Dis. 2014. PMID: 24602471 Review.
Tandem hemodialysis and plasma exchange.
Filler G, Clark WF, Huang SH. Filler G, et al. Among authors: clark wf. Pediatr Nephrol. 2014 Nov;29(11):2077-82. doi: 10.1007/s00467-013-2620-7. Epub 2013 Sep 11. Pediatr Nephrol. 2014. PMID: 24022368 Review.
A phase-II sequential case-series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab.
Clark WF, Rock G, Barth D, Arnold DM, Webert KE, Yenson PR, Kelton JG, Li L, Foley SR; members of Canadian Apheresis Group. Clark WF, et al. Br J Haematol. 2015 Jul;170(2):208-17. doi: 10.1111/bjh.13408. Epub 2015 Apr 8. Br J Haematol. 2015. PMID: 25855259 Free article. Clinical Trial.
196 results